Publications:

Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils.

Cancers

Behrens, Leonie M LM; van den Berg, Timo K TK; van Egmond, Marjolein M

Publication Date: 2022-07-11

Variant appearance in text: EGF: K322A

PubMed Link: 35884427

Variant Present in the following documents:

• Main text
• cancers-14-03366.pdf

View BVdb publication page

Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy.

Frontiers In Immunology

Almagro, Juan C JC; Daniels-Wells, Tracy R TR; Perez-Tapia, Sonia Mayra SM; Penichet, Manuel L ML

Publication Date: 2017

Variant appearance in text: EGF: K322A

PubMed Link: 29379493

Variant Present in the following documents:

• Main text

View BVdb publication page

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Frontiers In Immunology

Marshall, Michael J E MJE; Stopforth, Richard J RJ; Cragg, Mark S MS

Publication Date: 2017

Variant appearance in text: EGF: K322A

PubMed Link: 29046676

Variant Present in the following documents:

• Main text
• fimmu-08-01245.pdf

View BVdb publication page

High specificity targeting and detection of human neuroblastoma using multifunctional anti-GD2 iron-oxide nanoparticles.

Nanomedicine (London, England)

Baiu, Dana C DC; Artz, Nathan S NS; McElreath, Meghan R MR; Menapace, Bryan D BD; Hernando, Diego D; Reeder, Scott B SB; Grüttner, Cordula C; Otto, Mario M

Publication Date: 2015-10

Variant appearance in text: EGF: K322A

PubMed Link: 26420448

Variant Present in the following documents:

• Main text

View BVdb publication page